We are working of long-term vision of SCD control program by using four phase strategies:

1. Epidemiology: Prevalence studies, point of care diagnostic development, reporting system

2. Follow-up programs of SCD and Sickle cell carriers for marriage counseling and genetic counseling 

3. Pathogenesis program on SCD: Biomarker studies in SCD: DNA, RNA, Protein/ Genetic modifiers/ Serology / Virology/ Bacteriology

4. SCD Therapeutics: Transgenic mice facilities NY1DD and BERK and intravital microscopy, invivo and invitro models for testing antisickling agents